BioCardia, Inc.
BCDA
$1.36
-$0.03-2.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -31.58% | -10.59% | |||
| Gross Profit | 31.58% | 10.59% | |||
| SG&A Expenses | -19.18% | -42.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.45% | -24.76% | |||
| Operating Income | 27.45% | 24.76% | |||
| Income Before Tax | 27.62% | 24.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.62% | 24.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.62% | 24.45% | |||
| EBIT | 27.45% | 24.76% | |||
| EBITDA | 27.47% | 24.61% | |||
| EPS Basic | 41.68% | 30.77% | |||
| Normalized Basic EPS | 41.68% | 30.77% | |||
| EPS Diluted | 41.68% | 30.77% | |||
| Normalized Diluted EPS | 41.68% | 30.77% | |||
| Average Basic Shares Outstanding | 24.07% | 9.14% | |||
| Average Diluted Shares Outstanding | 24.07% | 9.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||